Sertraline vs. placebo for anxiety in kids with developmental disorders
Treatments studied
Part of Blood & lymphatic, Bones, joints & muscles, Brain & nervous system, Cancer, Genetic & congenital, Heart & circulation, Hormones & metabolism, Mental health clinical trials.
This trial compares sertraline (a common antidepressant) to a placebo (a pill with no medicine) to see which better reduces anxiety in children and teens who also have a neurodevelopmental disorder like autism, ADHD, or Tourette's. The goal is to help you and your child understand if this treatment might offer relief from anxiety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 8 and 17 years old.
- You have a diagnosed neurodevelopmental disorder, such as autism, ADHD, a tic disorder, Fragile X, tuberous sclerosis, or 22q11 deletion.
- You have one of these anxiety disorders: separation anxiety, social anxiety, agoraphobia, generalized anxiety, or another significant anxiety problem.
- Your anxiety is severe enough to have a score of 4 or higher on a standard severity scale.
- If you take other medications or use behavioral therapy, the doses and programs must have been stable for at least a month (or three months for therapy).
- You are able to complete study assessments in English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether sertraline (an anti-anxiety medicine) helps children and teens with generalized, separation, and/or social anxiety disorders. It also includes healthy children/teens for comparison so researchers can better understand safety and symptoms over time.
This trial tests whether buspirone, a medication that helps with anxiety, can reduce anxiety in children and teens with autism. It is a 12-week study where participants receive buspirone or a placebo (a pill with no medicine) to see if it improves anxiety symptoms.
This trial studies whether an antidepressant can help teens (ages 12–17) with anxiety disorders such as generalized, social, separation, or panic anxiety. It looks at both early and longer-term success of treatment, while monitoring safety closely with a caregiver.
This study tests whether a genetics-guided approach to choosing and adjusting escitalopram (an anxiety medicine) can improve safety and effectiveness for anxious teens. It also checks that participants have certain anxiety severity scores and can safely take the study medication.
This study tests if the antidepressant escitalopram can improve brain function in teenagers with autism. Participants will take the medicine and have brain scans (MRI) to see how it affects brain activity.
This trial compares two kinds of therapy for children with mild to moderate anxiety. It tests whether a stepped care approach works as well as group cognitive behavioral therapy (CBT) to help reduce anxiety.
Hear when a new Neurodevelopmental Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.